Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01848548 · ClinicalTrials.gov registry record
Superior Laryngeal Nerve Block For Awake Endotracheal Intubation Study
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 25
- Enrollment target
NCT01848548: Clinical Trial study, sponsored by Wake Forest University Health Sciences.
NCT01848548 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01848548 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
Awake tracheal intubation is the standard management for patients as risk for airway compromise. It is also commonly done in cases where there is significant cervical spine pathology i.e. cervical myelopathy or instability. The anesthetic technique used for the awake intubation is crucial to the patient's safety. One of the most important aspects of the anesthetic technique is airway anesthesia prior to placement of an endotracheal tube. The superior laryngeal nerve is responsible for mediating the cough reflex around the vocal cords. The investigators have developed an approach to reliably block the superior laryngeal nerve by injecting local anesthetic near the nerve in a unique approach. Injecting local anesthetic into or through the thyrohyoid membrane will effectively block the superior laryngeal nerve
Interventions
- PROCEDURE Superior Laryngeal Nerve Block using the Thyrohyoid Membrane as an Anatomic Landmark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2013-04 |
| Est. Completion | 2017-07 |
Why NCT01848548 stopped before completion
NCT01848548 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Superior Laryngeal Nerve Block using the Thyrohyoid Membrane as an Anatomic Landmark is the first listed.
NCT01848548 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01848548 about?
NCT01848548 is a clinical study titled "Superior Laryngeal Nerve Block For Awake Endotracheal Intubation Study". Awake tracheal intubation is the standard management for patients as risk for airway compromise. It is also commonly done in cases where there is significant cervical spine pathology i.e. cervical myelopathy or instability. The anesthetic technique used for the awake intubation is crucial to the pat...
What is the current status of trial NCT01848548?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 2013-04. Estimated completion is 2017-07.
What interventions are being tested in trial NCT01848548?
The interventions under investigation include: Superior Laryngeal Nerve Block using the Thyrohyoid Membrane as an Anatomic Landmark (PROCEDURE).
Who is sponsoring clinical trial NCT01848548?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia